Ton Dang

Ton Dang has a strong background in scientific research and analysis. Ton started their career as a Research Associate at Hyseq Pharmaceutical in 2000 and worked there until 2002. Ton then joined UCSF General Hospital as a Research Associate from 2003 to 2004. Ton then joined Amgen in 2004 as a Scientist II, where they were responsible for performing drug-drug interaction studies, enzymatic stability studies, and bioanalytical analysis. Ton worked at Amgen until October 2022 when ChemoCentryx was acquired by Amgen. Currently, Ton works at Septerna as a Staff Scientist starting from March 2023.

Ton Dang earned a Bachelor's degree in Biotechnology from the University of California, Davis, from 1996 to 1999. Later, from 2000 to 2001, they obtained a Certificate in Bioinformatics from the University of Santa Cruz Extension.